Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Kidney Disease Market Poised To Hit $159.58 Billion By 2030 With A 6.9% CAGR
The kidney disease market has experienced robust expansion recently. Projections indicate its value will increase from $114.39 billion in 2025 to $121.98 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.6%. This historical growth is attributable to several factors, including the increasing prevalence of chronic kidney disease, a rise in diabetes and hypertension cases, the established application of dialysis and medication treatments, the expansion of hospital-based renal care services, and the broadened accessibility of diagnostic testing.
The kidney disease market is projected to experience substantial expansion over the upcoming years. Its valuation is anticipated to reach $159.58 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.9%. This projected increase is fueled by factors such as an aging worldwide populace with elevated renal risk, a rise in the use of home-based dialysis, increased funding for kidney disease research, a heightened emphasis on early screening initiatives, and broader availability of renal care in developing markets. Key developments during this timeframe encompass a stronger emphasis on early detection and effective disease management, the increasing acceptance of dialysis and renal replacement therapies, a surging need for customized kidney disease treatments, the expansion of comprehensive multidisciplinary care approaches for renal patients, and enhanced patient understanding coupled with preventive care efforts.
Get A Free Sample Report With In-Depth Market Insights:
Kidney Disease Market Growth Catalysts And Demand Drivers
The rising occurrence of kidney ailments is anticipated to fuel expansion in the kidney disease market moving ahead. Kidney diseases encompass various disorders that impact the structural integrity and operational capabilities of the kidneys. Medications for kidney disorders are utilized to lower patients’ blood pressure and reduce protein loss, which helps in slowing the progression of kidney damage, managing associated symptoms, and preventing potential complications. For instance, in June 2023, according to Kidney Research UK, a UK-based charitable organization dedicated to research and advocacy for improving the understanding, prevention, and treatment of kidney diseases, an estimated 7.19 million people in the UK were affected by chronic kidney disease in 2023, representing more than 10% of the UK population, with projections showing an increase to 7.61 million people by 2033. Consequently, the increasing incidence of kidney diseases is driving the growth of the kidney disease market.
Kidney Disease Market Segment Analysis: What Are The Core Market Categories?
The kidney disease market covered in this report is segmented –
1) By Treatment: Medication, Dialysis, Surgery, Other Treatments
2) By Indication: Acute Kidney Injury, Chronic Kidney Disease, End-Stage Renal Disease, Other Indications
3) By Route Of Administration: Oral, Parenteral
4) By End-User: Hospitals, Diagnostic Laboratories, Other End-Users
Subsegments:
1) By Medication: Antihypertensives, Erythropoiesis-Stimulating Agents (ESAs), Phosphate Binders, Vitamin D Analogs, Immunosuppressants
2) By Dialysis: Hemodialysis, Peritoneal Dialysis
3) By Surgery: Kidney Transplant, Nephrectomy, Renal Artery Bypass, Ureteral Surgery
4) By Other Treatments: Lifestyle And Dietary Modifications, Renal Replacement Therapy, Palliative Care
Kidney Disease Market Trends Shaping Long-Term Demand
Leading companies in the kidney disease market are focusing on integrating technology-driven innovations, such as compact, cartridge-based hemodialysis systems, to enhance flexibility in treatment, patient convenience, and workflow efficiency. These compact, cartridge-based hemodialysis systems are portable dialysis devices that utilize disposable dialysate cartridges instead of traditional bagged fluids, which enables features like automated dialysate preparation, simplified setup, and improved suitability for home-based therapy. For instance, in November 2024, Quanta Dialysis Technologies, a UK-based dialysis technology company, obtained FDA clearance for the Quanta Dialysis System, a cartridge-based hemodialysis system designed to support home hemodialysis and adaptable deployment in various care settings, characterized by a compact footprint, on-demand dialysate generation, and an intuitive touchscreen interface. The Quanta Dialysis System advances patient autonomy, simplifies treatment delivery, and boosts operational efficiency across dialysis settings.
Kidney Disease Market Top Companies Driving Competitive Growth
Major companies operating in the kidney disease market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Novartis AG, AstraZeneca plc, Sanofi S.A., Bristol-Myers Squibb Company, AbbVie Inc., Bayer AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Boehringer Ingelheim International GmbH, Astellas Pharma Inc., Otsuka Pharmaceutical Co. Ltd., Mitsubishi Tanabe Pharma Corporation, Kyowa Kirin Co. Ltd., Vertex Pharmaceuticals Inc., Gilead Sciences Inc., Teva Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Limited, Lupin Limited, Aurobindo Pharma Limited
View The Full Kidney Disease Market Report:
Kidney Disease Market Geographic Landscape: Which Region Leads Industry Growth?
North America was the largest region in the kidney disease market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the kidney disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model








